Benchtop-MRI for in vivo imaging using a macromolecular contrast agent based on hydroxyethyl starch (HES)

2011 ◽  
Vol 417 (1-2) ◽  
pp. 196-203 ◽  
Author(s):  
Ahmed Besheer ◽  
Henrike Caysa ◽  
Hendrik Metz ◽  
Thomas Mueller ◽  
Jörg Kressler ◽  
...  
2020 ◽  
Vol 47 (2) ◽  
pp. 0207033
Author(s):  
于静文 Yu Jingwen ◽  
王秀翃 Wang Xiuhong ◽  
冯金超 Feng Jinchao ◽  
张娜 Zhang Na ◽  
王璞 Wang Pu

2015 ◽  
Vol 137 (28) ◽  
pp. 9108-9116 ◽  
Author(s):  
Victoria S. R. Harrison ◽  
Christiane E. Carney ◽  
Keith W. MacRenaris ◽  
Emily A. Waters ◽  
Thomas J. Meade

2019 ◽  
Vol 55 (42) ◽  
pp. 5851-5854 ◽  
Author(s):  
Lianhua Liu ◽  
Yaping Yuan ◽  
Yuqi Yang ◽  
Michael T. McMahon ◽  
Shizhen Chen ◽  
...  

A fluorinated aza-BODIPY derivative BDPF was developed as a small molecule contrast agent, which displayed highly efficient near infrared fluorescence/photoacoustic/19F MR tri-modality tumor imaging.


2009 ◽  
Vol 193 (5) ◽  
pp. W437-W441 ◽  
Author(s):  
Maarten Truijers ◽  
Jurgen J. Fütterer ◽  
Satoru Takahashi ◽  
Roel A. Heesakkers ◽  
Jan D. Blankensteijn ◽  
...  

2012 ◽  
Vol 8 (4S_Part_19) ◽  
pp. P696-P696
Author(s):  
Mathieu Santin ◽  
Thomas Debeir ◽  
Thomas Rooney ◽  
Marc Dhenain

2018 ◽  
Vol 6 (1) ◽  
pp. 207-215 ◽  
Author(s):  
Wen Xu ◽  
Jinghua Sun ◽  
Liping Li ◽  
Xiaoyang Peng ◽  
Ruiping Zhang ◽  
...  

A magnetic resonance imaging contrast agent, based on Mn2+-chelating melanin nanoparticles, that has ultrahigh efficient clearance in vivo for tumor-targeted imaging.


Small ◽  
2016 ◽  
Vol 12 (29) ◽  
pp. 3995-4006 ◽  
Author(s):  
Hongyuan Shi ◽  
Zhiming Wang ◽  
Chusen Huang ◽  
Xiaoli Gu ◽  
Ti Jia ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-11 ◽  
Author(s):  
Hyeona Yim ◽  
Seogjin Seo ◽  
Kun Na

Various imaging technologies have become increasingly important in developing a better understanding of information on the biological and clinical phenomena associated with diseases of interest. Of these technologies, magnetic resonance imaging (MRI) is one of the most powerful for clinical diagnosis and in vivo imaging without the exposure to ionising radiation or radiotracers. Despite its many advantages, there are intrinsic limitations caused by MRI contrast agents, such as short vascular half-life circulation, which lead to unwanted side effects. In this review, we will focus on the multifunctional modification of MRI contrast agents for diagnosis and therapy.


Sign in / Sign up

Export Citation Format

Share Document